The European Commission has awarded a consortium led by AMT Medical including HEMEX with a 2.2 MEUR grant under its “Fast-Track to Innovation (FTI)” program.
Under the proposal HEMEX will plan, coordinate and execute a multicentric, pan-European study in order to obtain CE-mark for the Excimer Laser Assisted Non-occlusive Anastomosis (ELANA) Heart Bypass System in Patients undergoing Coronary Artery Bypass Grafts (CABG), with the goal of achieving market approval in less than 36 months.
For more information on the progress of this life-changing therapy, please contact franziska.stemmler@hemex.ch. If you need advice on obtaining non-dilutive funding, help with writing your proposal, or forming a consortium with experienced partners, get in touch with us.
Co-funded by the Horizon 2020 Framework Programme of the European Union and the Grant Agreement (GA) No. 869922.